WHO WE ARE →
WHAT WE DO →
OUR STORIES →
THE KIDNEY CANCER COMMUNITY →
DONATE →
CONTACT →
Apr 29, 2026
How one family’s huddle turned into a $53,000 movement — and a master class in the kind of stubborn, almost-delusional hope that fuels kidney cancer research. Veronica McLaughlin will tell you, with a laugh, that she has “delusions of grandeur.” When she started planning a March fundraising...
ADVOCACY DAYS 2027 →
Apr 29, 2026
How one family’s huddle turned into a $53,000 movement — and a master class in the kind of stubborn, almost-delusional hope that fuels kidney cancer research. Veronica McLaughlin will tell you, with a laugh, that she has “delusions of grandeur.” When she started planning a March fundraising...
Welcome to the newly updated Patient Resource Center. We’ve refreshed everything to make it easier to find clear, trustworthy information to guide you through your kidney cancer journey.
KCRS: KIDNEY CANCER RESEARCH SUMMIT →
RESEARCH GRANTS & AWARDS →
NEWS →
Jan 30, 2026
KidneyCAN CEO Bryan Lewis recently spent a full day immersed in one of the most dynamic kidney cancer research environments in the country: UC San Diego Health, guided by Dr. Rana McKay, a nationally recognized medical oncologist and leader in genitourinary (GU) cancer research. From breathtaking...
Apr 29, 2026
How one family’s huddle turned into a $53,000 movement — and a master class in the kind of stubborn, almost-delusional hope that fuels kidney cancer research. Veronica McLaughlin will tell you, with a laugh, that she has “delusions of grandeur.” When she started planning a March fundraising...
Mar 15, 2025 | Microblog | 0 comments
The Full-Year Continuing Appropriations and Extensions Act, 2025, redirects 57% of CDMRP funding to other Defense Health Agency areas. As a result, the KCRP receives no funding for FY25—putting research projects on hold, delaying new treatments, and risking the loss of top researchers.
